Hormone Replacement Therapy Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Hormone Replacement Therapy Market
Hormone Replacement Therapy Market: By Product (Estrogen Replacement Therapy & Others); By Route (Oral, Parenteral, Others), By Disease (Menopause, Male Hypogonadism, Others) & By Region (North America, Europe, Others) - Forecast(2018 - 2023)
Report Code : HCR 0222
Updated Date: 16 May, 2018  

1. Hormone Replacement Therapy Market –Overview
2. Executive Summary
3. 
Hormone Replacement Therapy Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Hormone Replacement Therapy Market–Forces
   4.1. Drivers
      4.1.1. Development of highly innovative drug delivery systems
      4.1.2. Rise in the number of menopausal women
      4.1.3. Increasing awareness on post-menopausal hazards
   4.2. Restraints
      4.2.1. Higher cost of therapy
      4.2.2. Risk of cancer and blood clotting
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of anti-aging therapy and newer formulations
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Hormone Replacement Therapy Market, By Product
   5.1. Estrogen Replacement Therapy
   5.2. Human Growth Hormone Replacement Therapy
   5.3. Thyroid Replacement Therapy
   5.4. Others
6. Hormone Replacement Therapy Market, By Route
   6.1. Oral
   6.2. Parenteral
   6.3. Transdermal
   6.4. Others
7. Hormone Replacement Therapy Market, By Disease
   7.1. Menopause
   7.2. Hypothyroidism
   7.3. Male Hypogonadism
   7.4. Growth Hormone Deficiency
   7.5. Others
8. Hormone Replacement Therapy Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Hormone Replacement Therapy – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   10.1. Abbott Point of Care, Inc.
   10.2. Merck &Co. Inc.
   10.3. Bayer Pharma AG
   10.4. QuatRx Pharmaeuticals
   10.5. Hisamitsu Pharmaceutical Co., Inc.
   10.6. Actavis Plc.
   10.7. Novo Nordisk
   10.8. Mylan Laboratories
   10.9. Novartis AG
   10.10. Pfizer Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll